Comparison of tamoxifen with danazol for treatment of cyclical mastalgia
RCT
OA: closed
CC0
⤵ 12 in-corpus citations
AI-generated summary
Tamoxifen and danazol were compared to placebo for cyclical mastalgia, with tamoxifen showing superior pain relief and sustained symptom-free status compared to danazol and placebo.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
This study evaluates the benefits and side-effects of two drugs (tamoxifen or danazol) used randomly in women with severe cyclical mastalgia. Ninety-three patients with severe cyclical mastalgia of more than 6 months duration were randomly selected for treatment with tamoxifen (32 women), danazol (32 women) or placebo (29 women) for six consecutive cycles. A standard protocol was used, which included pain relief as measured by linear analog, side-effects and cost. Statistical analysis was performed using the non-parametric Mann-Whitney U or Kruskall-Wallis tests and Student's t-test. As measured by linear analog scoring, pain relief was achieved in 23/32 (72%) of those receiving tamoxifen, 21/32 (65%) of those taking danazol (p < or = 0.001) and 11/29 (38%) of those taking placebo. Twelve months after the end of treatment, 17 (53%) women who received tamoxifen were still free of symptoms, as compared with 12 (37%) of the danazol-treated patients (p < 0.001) and none of the placebo-treated patients. These results suggest that tamoxifen is highly efficaceous and cost effective for the management of severe cyclical mastalgia.
My notes (saved in your browser only)
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (20)
- Clinical experience of drug treatments for mastalgia via openalex
- Non-cyclical mastalgia: an improved classification and treatment via openalex
- doi:10.1016/0022-4731(74)90139-3 via openalex
- doi:10.1002/bjs.1800750905 via openalex
- W1671073 via openalex
- W65823985 via openalex
- doi:10.1200/jco.1993.11.3.485 via openalex
- doi:10.1093/jnci/86.7.527 via openalex
- doi:10.1136/bmj.281.6253.1450 via openalex
- doi:10.1097/00003081-199412000-00018 via openalex
- doi:10.1016/s0305-7372(78)80017-6 via openalex
- W2418620926 via openalex
- doi:10.1016/b978-0-7020-2774-1.00012-8 via openalex
- doi:10.1111/j.1600-0412.1988.tb07804.x via openalex
- doi:10.1016/s0140-6736(76)92465-x via openalex
- doi:10.1097/00006250-197907000-00018 via openalex
- doi:10.1016/0002-9378(81)90417-8 via openalex
- doi:10.1056/nejm198902233200802 via openalex
- doi:10.1016/s0015-0282(16)54838-9 via openalex
- doi:10.1136/bmj.1.4818.1007 via openalex
Cited by (8)
- Danazol 2022
- A Comparative Study of Danazol alone with Danazol Combined with Evening Primrose Oil in the Treatment of Fibrocystic Breast Disease 2022
- The Value of Danazol in the Conservative Treatment and Long-Term Control of Fibrocystic Disease of the Breast 2016
- Toremifene in premenstrual mastalgia 2013
- Evidence-based management of Mastalgia: a meta-analysis of randomised trials 2007
- [Danazol effectivity in control of moderate to severe mastalgia] 2005
- Evaluation and management of breast pain 2004
- Benign breast disease 2001
Source provenance
- openalex
- last seen: 2026-05-11T06:38:17.545654+00:00
- pubmed
- last seen: 2026-10-08T22:00:28.864438+00:00
- unpaywall
- last seen: 2026-10-10T06:25:47.132674+00:00
License: CC0
· commercial use OK